UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma

British journal of cancer, 2019-01, Vol.120 (2), p.165-171

2019

Volltextzugriff (PDF)

A randomized dose‐response trial of aerobic exercise and health‐related quality of life in colon cancer survivors

Psycho-oncology (Chichester, England), 2018-04, Vol.27 (4), p.1221-1228

2018

Volltextzugriff (PDF)

Effects of exercise on circulating tumor cells among patients with resected stage I-III colon cancer

PloS one, 2018-10, Vol.13 (10), p.e0204875-e0204875

2018

Volltextzugriff (PDF)

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing

Frontiers in oncology, 2022-07, Vol.12, p.859846

2022

Volltextzugriff (PDF)

Dose-Response Effects of Aerobic Exercise among Colon Cancer Survivors: A Randomized Phase II Trial

Clinical colorectal cancer, 2018-03, Vol.17 (1), p.32-40

2018

Volltextzugriff (PDF)

Utility of bevacizumab in advanced hepatocellular carcinoma: A veterans affairs experience

Cancer medicine (Malden, MA), 2019-04, Vol.8 (4), p.1442-1446

2019

Volltextzugriff (PDF)

97856 Implementation of DPYD and UGT1A1 pharmacogenetic testing to guide chemotherapy dosing

Journal of clinical and translational science, 2021-03, Vol.5 (s1), p.103-104

2021

Volltextzugriff (PDF)

Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Neutropenia during Phase I Development of Liposome-Entrapped Paclitaxel

Clinical cancer research, 2008-09, Vol.14 (18), p.5856-5863

2008

Volltextzugriff (PDF)

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

The lancet oncology, 2018-07, Vol.19 (7), p.940-952

2018

Volltextzugriff (PDF)

Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck

JNCI : Journal of the National Cancer Institute, 2019-05, Vol.111 (5), p.490-497

2019

Volltextzugriff (PDF)

Implementing DPYD/UGT1A1 testing to prevent treatment related adverse events (TRAE) in patients with gastrointestinal (GI) cancer: Results of a pragmatic implementation trial

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.10599-10599

2024

Volltextzugriff (PDF)

Commentary: Colonoscopic Findings and Tumor Site Do Not Predict Bowel Obstruction During Medical Treatment of Stage IV Colon Cancer

The oncologist (Dayton, Ohio), 2009-06, Vol.14 (6), p.578-579

Damjanov, Nevena

2009

Volltextzugriff (PDF)

Outcomes of an advanced practice nurse (APN)-led cancer genetics service

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.71-71

2022

Volltextzugriff (PDF)

Phase II Trial of Palbociclib in Patients with Advanced Esophageal or Gastric Cancer

The oncologist (Dayton, Ohio), 2020-12, Vol.25 (12), p.e1864-e1868

2020

Volltextzugriff (PDF)

Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma: The Phase I–II Hydroxychloroquine-Transarterial Chemoembolization (qTACE) Trial

Journal of vascular and interventional radiology, 2024-08

2024

Volltextzugriff (PDF)

Integrated Capecitabine–Temozolomide with Radioembolization for Liver-Dominant G2 NETs: Long-Term Outcomes of a Single-Institution Retrospective Study

Cardiovascular and interventional radiology, 2024, Vol.47 (1), p.60-68

2024

Volltextzugriff (PDF)

Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as "cholangioblastic variant of intrahepatic cholangiocarcinoma

Human pathology, 2017-04, Vol.62, p.232-241

2017

Volltextzugriff (PDF)

Dose–response effects of aerobic exercise on body composition among colon cancer survivors: a randomised controlled trial

British journal of cancer, 2017-11, Vol.117 (11), p.1614-1620

2017

Volltextzugriff (PDF)

DPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical Implementation

Pharmacotherapy, 2020-11, Vol.40 (11), p.1108-1129

2020

Volltextzugriff (PDF)

Resection of the Primary Colorectal Cancer Is Not Necessary in Nonobstructed Patients with Metastatic Disease

The oncologist (Dayton, Ohio), 2009-10, Vol.14 (10), p.963-969

2009

Volltextzugriff (PDF)

Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data

Cancer, 2019-02, Vol.125 (3), p.406-415

2019

Volltextzugriff (PDF)

A pilot study of galunisertib (LY2157299 monohydrate) plus stereotactic body radiotherapy (SBRT) in advanced hepatocellular carcinoma (HCC)

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.270-270

2019

Volltextzugriff (PDF)

Peripheral blood immune correlates associated with TGF-β inhibition (galunisertib) and stereotactic body radiotherapy (SBRT) in patients with advanced hepatocellular carcinoma (HCC)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.4575-4575

2020

Volltextzugriff (PDF)

Safety and Feasibility of Integrating Yttrium-90 Radioembolization With Capecitabine-Temozolomide for Grade 2 Liver-Dominant Metastatic Neuroendocrine Tumors

Pancreas, 2018-09, Vol.47 (8), p.980-984

2018

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(73)

Publikationsform

Artikel
(77)
Reviews
(4)

Sprache

Englisch
(80)
Serbian
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma

A randomized dose‐response trial of aerobic exercise and health‐related quality of life in colon cancer survivors

Effects of exercise on circulating tumor cells among patients with resected stage I-III colon cancer

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing

Dose-Response Effects of Aerobic Exercise among Colon Cancer Survivors: A Randomized Phase II Trial

Utility of bevacizumab in advanced hepatocellular carcinoma: A veterans affairs experience

97856 Implementation of DPYD and UGT1A1 pharmacogenetic testing to guide chemotherapy dosing

Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Neutropenia during Phase I Development of Liposome-Entrapped Paclitaxel

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study

Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck

Implementing DPYD/UGT1A1 testing to prevent treatment related adverse events (TRAE) in patients with gastrointestinal (GI) cancer: Results of a pragmatic implementation trial

Commentary: Colonoscopic Findings and Tumor Site Do Not Predict Bowel Obstruction During Medical Treatment of Stage IV Colon Cancer

Outcomes of an advanced practice nurse (APN)-led cancer genetics service

Phase II Trial of Palbociclib in Patients with Advanced Esophageal or Gastric Cancer

Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma: The Phase I–II Hydroxychloroquine-Transarterial Chemoembolization (qTACE) Trial

Integrated Capecitabine–Temozolomide with Radioembolization for Liver-Dominant G2 NETs: Long-Term Outcomes of a Single-Institution Retrospective Study

Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as "cholangioblastic variant of intrahepatic cholangiocarcinoma

Dose–response effects of aerobic exercise on body composition among colon cancer survivors: a randomised controlled trial

DPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical Implementation

Resection of the Primary Colorectal Cancer Is Not Necessary in Nonobstructed Patients with Metastatic Disease

Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data

A pilot study of galunisertib (LY2157299 monohydrate) plus stereotactic body radiotherapy (SBRT) in advanced hepatocellular carcinoma (HCC)

Peripheral blood immune correlates associated with TGF-β inhibition (galunisertib) and stereotactic body radiotherapy (SBRT) in patients with advanced hepatocellular carcinoma (HCC)

Safety and Feasibility of Integrating Yttrium-90 Radioembolization With Capecitabine-Temozolomide for Grade 2 Liver-Dominant Metastatic Neuroendocrine Tumors

Suchergebnisse filtern